Clarius Group LLC’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$140K Hold
2025
Q2
$145K Hold
2025
Q1
$151K Hold
2024
Q4
$193K Hold
2024
Q3
$188K Hold
2024
Q2
$215K Hold
2024
Q1
$285K Hold
2023
Q4
$282K Hold
2023
Q3
$219K Hold
2023
Q2
$214K Hold
2023
Q1
$191K Hold
2022
Q4
$221K Hold
2022
Q3
$304K Hold
2022
Q2
$233K Buy
2022
Q1
$233K Hold
2021
Q4
$233K Buy